Skip to main content
OpenTrials

Clinical trial condition

Locally Advanced or Metastatic Breast Cancer

Explore clinical trials studying Locally Advanced or Metastatic Breast Cancer. Study availability and eligibility vary by location and protocol.

18 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Locally Advanced or Metastatic Breast Cancer trial results

Active, not recruiting

A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

NCT06680921

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • The First Affiliated Hispital of Bengbu Medical University Bengbu, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • The First Affiliated Hispital of Anhui Medical University Hefei, Anhui, China
  • Maanshan People's Hospital Maanshan, Anhui, China
View all 57 locations
View Trial Details
Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer)

NCT05296798

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • Arizona Clinical Research Center, Inc Tucson, Arizona, United States
  • Los Angeles Hematology Oncology Medical Group Los Angeles, California, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Maryland Oncology Hematology - Annapolis Annapolis, Maryland, United States
View all 202 locations
View Trial Details
Active, not recruiting

A Phase IIIB Study to Evaluate the Use of Capivasertib in Combination With Fulvestrant in Patients With Advanced Breast Cancer Who Have Relapsed/Progressed on ET and CDK4/6 Inhibitor Reflecting Real World Clinical Practice in Spain

NCT06764186

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • Research Site Alicante, Spain
  • Research Site Barcelona, Spain
  • Research Site Barcelona, Spain
  • Research Site Barcelona, Spain
View all 17 locations
View Trial Details
Completed

Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

NCT03781063

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Yuma Regional Medical Center (JIT) Yuma, Arizona, United States
  • City of Hope Comprehensive Cancer Duarte, California, United States
  • Compassionate Care Research Group Fountain Valley, California, United States
View all 51 locations
View Trial Details
Completed

GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer

NCT05054751

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • The First Affiliated Hospital of Bengbu Medical College Bengbu, Anhui, China
  • Anhui Provincial Cancer Hospital Hefei, Anhui, China
  • The Second Hospital of Anhui Medical University Hefei, Anhui, China
  • Beijing Chaoyang Hospital of Capital Medical University Beijing, Beijing Municipality, China
View all 54 locations
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants

NCT03437083

Conditions
Breast Diseases, Breast Neoplasms, Locally Advanced or Metastatic Breast Cancer, +4 more
Locations
  • Eisai Trial site_03 Ansan, South Korea
  • Eisai Trial site_04 Busan, South Korea
  • Eisai Trial site_05 Busan, South Korea
  • Eisai Trial site_06 Busan, South Korea
View all 14 locations
View Trial Details

Related conditions